Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124920392 | 12492039 | 2 | F | 2012 | 20160705 | 20160623 | 20160719 | EXP | US-ACORDA-ACO_125147_2016 | ACORDA | 0.00 | F | Y | 63.49000 | KG | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124920392 | 12492039 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
| 124920392 | 12492039 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 22250 | 10 | MG | TABLET | BID | ||||||
| 124920392 | 12492039 | 3 | C | TYSABRI | NATALIZUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 124920392 | 12492039 | 4 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | UNK | U | 0 | |||||||||
| 124920392 | 12492039 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK | U | 0 | |||||||||
| 124920392 | 12492039 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | Unknown | UNK | U | 0 | |||||||||
| 124920392 | 12492039 | 7 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 124920392 | 12492039 | 8 | C | Omega-3 fatty acids | OMEGA-3 FATTY ACIDS | 1 | Unknown | UNK | U | 0 | |||||||||
| 124920392 | 12492039 | 9 | C | Coq10 | UBIDECARENONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124920392 | 12492039 | 10 | C | Black cohosh | BLACK COHOSH | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124920392 | 12492039 | 1 | Gait disturbance |
| 124920392 | 12492039 | 3 | Product used for unknown indication |
| 124920392 | 12492039 | 4 | Product used for unknown indication |
| 124920392 | 12492039 | 5 | Product used for unknown indication |
| 124920392 | 12492039 | 6 | Product used for unknown indication |
| 124920392 | 12492039 | 7 | Product used for unknown indication |
| 124920392 | 12492039 | 8 | Product used for unknown indication |
| 124920392 | 12492039 | 9 | Product used for unknown indication |
| 124920392 | 12492039 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124920392 | 12492039 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124920392 | 12492039 | Breast cancer | |
| 124920392 | 12492039 | Contusion | |
| 124920392 | 12492039 | Drug ineffective | |
| 124920392 | 12492039 | Fall |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124920392 | 12492039 | 1 | 2012 | 201602 | 0 | |
| 124920392 | 12492039 | 2 | 20160630 | 0 |